Observational Study of Systemic Lupus Erythematosus in Gullah Health
This study is looking at Systemic Lupus Erythematosus (SLE), an autoimmune disease where your body's immune system attacks its own tissues. Researchers want to understand why African Americans are more likely to get SLE and often have more severe cases. They believe specific genetic factors, combined with environmental exposures, play a role. This study is focusing on the Gullah population from the Sea Islands of South Carolina and Georgia because their unique genetic background can help researchers explore these connections. You may be able to join if you are African-American Gullah, aged 2 or older, and either have SLE, are a relative of someone with SLE, or are a healthy Gullah control. The study aims to enroll 750 participants. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will observe and collect information without providing any specific treatments. It aims to include 750 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Systemic Lupus Erythematosus in Gullah Health
At a glance
A primary outcome measure isn't published for this study.
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Diane L. Kamen, MD, MSCR · PRINCIPAL_INVESTIGATOR · Medical University of South Carolina
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.